Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,689 public trials 1,036 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

NCT04310020

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 171 locations
View Trial Details
Active, Not Recruiting

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

NCT05663866

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Compassionate Cancer Care Fountain Valley, California, United States
  • Virginia Cancer Specialists Fairfax, Virginia, United States
  • UW Medicine Valley Medical Center Renton, Washington, United States
  • CHU de Brest - Hopital de la Cavale Blanche Brest, France
View all 36 locations
View Trial Details
Active, Not Recruiting

REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)

NCT05973773

Conditions
Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Comprehensive Cancer Centers of Nevada - Henderson Henderson, Nevada, United States
  • Comprehensive Cancer Centers of Nevada - Horizon Ridge Henderson Henderson, Nevada, United States
  • Comprehensive Cancer Centers of Nevada - Southeast Henderson - Stephanie Henderson, Nevada, United States
  • Comprehensive Cancer Centers of Nevada - Summerlin Medical Center II Las Vegas, Nevada, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

NCT06710132

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • University of California - Los Angeles - 300208353 Santa Monica, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
  • Georgetown University - Lombardi Comprehensive Cancer Center - 1134847 Washington D.C., District of Columbia, United States
  • D&H Cancer Research Center Margate, Florida, United States
View all 81 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC

NCT04606771

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Ciudad de Buenos Aires, Argentina
  • Research Site Delhi, India
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure

NCT04988295

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Southern Cancer Center, PC Mobile, Alabama, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 249 locations
View Trial Details
Active, Not Recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Lake City, Florida, United States
  • Research Site Hinsdale, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations

NCT06644768

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of California San Diego (Ucsd)-Moores Cancer Center La Jolla, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Mayo Clinic Hospital Jacksonville, Florida, United States
View all 35 locations
View Trial Details

Related conditions